Works matching DE "ARIAD Pharmaceuticals Inc."
Results: 26
Ariad Pharmaceuticals Wins First Round Over Eli Lilly, Patents on Methods Can Be Far-reaching.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2006, v. 98, n. 15, p. 1028, doi. 10.1093/jnci/djj340
- By:
- Publication type:
- Article
DNA patents and diagnostics: not a pretty picture.
- Published in:
- Nature Biotechnology, 2010, v. 28, n. 8, p. 784, doi. 10.1038/nbt0810-784
- By:
- Publication type:
- Article
Ariad's NF-κB blow.
- Published in:
- Nature Biotechnology, 2010, v. 28, n. 5, p. 389, doi. 10.1038/nbt0510-389a
- By:
- Publication type:
- Article
Ariad's NFκB patent claims shot down on appeal.
- Published in:
- Nature Biotechnology, 2009, v. 27, n. 6, p. 494, doi. 10.1038/nbt0609-494b
- By:
- Publication type:
- Article
Patently absurd?
- Published in:
- Nature Biotechnology, 2006, v. 24, n. 7, p. 737, doi. 10.1038/nbt0706-737
- By:
- Publication type:
- Article
A license to print money?
- Published in:
- Nature Biotechnology, 2006, v. 24, n. 6, p. 593, doi. 10.1038/nbt0606-593
- Publication type:
- Article
ARIAD PHARMACEUTICALS, INC. V. ELI LILLYAND Co.
- Published in:
- Berkeley Technology Law Journal, 2011, v. 26, n. 1, p. 367
- Publication type:
- Article
RECOMBINATION.
- Published in:
- Bio-IT World, 2003, v. 2, n. 11, p. 20
- Publication type:
- Article
MARKETPLACE.
- Published in:
- Oncology Exchange, 2015, v. 14, n. 2, p. 33
- Publication type:
- Article
Drug & therapeutics update.
- Published in:
- 2013
- Publication type:
- Product Review
Product Preview.
- Published in:
- 2005
- Publication type:
- Product Review
Orphan Drug Status.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 10, p. 22
- Publication type:
- Article
ENCOURAGING FURTHER INNOVATION: ARIAD v. ELI LILLY AND THE WRITTEN DESCRIPTION REQUIREMENT.
- Published in:
- Seton Hall Law Review, 2012, v. 42, n. 3, p. 1287
- By:
- Publication type:
- Article
IMMATERIAL TO INNOVATION: THE STORY OF ARIAD PHARMACEUTICALS, INC. V. ELI LILLY & CO.
- Published in:
- Brooklyn Journal of Corporate, Financial & Commercial Law, 2011, v. 5, n. 2, p. 503
- By:
- Publication type:
- Article
THE ONTOLOGICAL FUNCTION OF THE PATENT DOCUMENT.
- Published in:
- University of Pittsburgh Law Review, 2012, v. 74, n. 2, p. 263, doi. 10.5195/lawreview.2012.194
- By:
- Publication type:
- Article
Patent watch.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 5, p. 352, doi. 10.1038/nrd3177
- Publication type:
- Article
Patent watch.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 10, p. 764, doi. 10.1038/nrd3017
- By:
- Publication type:
- Article
Patent watch.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 5, p. 350, doi. 10.1038/nrd2889
- By:
- Publication type:
- Article
Ariad and Lilly square up for battle.
- Published in:
- Nature Reviews Drug Discovery, 2006, v. 5, n. 5, p. 366, doi. 10.1038/nrd2054
- Publication type:
- Article
Patent Watch.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 9, p. 662
- Publication type:
- Article
As leukemia options grow, drugs jockey to be first-line therapies.
- Published in:
- Nature Medicine, 2013, v. 19, n. 1, p. 7, doi. 10.1038/nm0113-7
- By:
- Publication type:
- Article
INNOVATION ON THE CUTTING EDGE OF ARIAD: REINVENTING THE WRITTEN DESCRIPTION REQUIREMENT.
- Published in:
- New York University Law Review, 2011, v. 86, n. 6, p. 1895
- By:
- Publication type:
- Article
Going it alone.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 5, p. 411, doi. 10.1038/nbt.2896
- Publication type:
- Article
First Rounders Podcast: Harvey Berger.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 1, p. 23, doi. 10.1038/nbt0114-23
- Publication type:
- Article
FDA halts then allows sales of Ariad's leukemia medication.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 1, p. 9, doi. 10.1038/nbt0114-9a
- By:
- Publication type:
- Article
Research briefs.
- Published in:
- Chemistry & Industry, 2007, n. 14, p. 8
- Publication type:
- Article